Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: A prospective controlled study with one-year follow-up

Journal of Vascular Surgery

Volumn 31, Issue 4, 2000, Pages 650-661

  Delis, Konstantinos T ^a   Nicolaides, Andrew N ^a   Wolfe, John H N ^a   Stansby, Gerard ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; COMPRESSION THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMITTENT CLAUDICATION; MALE; PNEUMATIC TOOL; PRIORITY JOURNAL; PROSPECTIVE STUDY; WALKING;

EID: 0034002885     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.103969     Document Type: Article

References (65)

1. Kannel WB, McGee DL. Update on some epidemiological features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985;33:13-8.
2. Vogt MT, Cauley JA, Kuller LH, Hulley SB. Prevalence and correlates of lower extremity arterial disease in elderly women. Am J Epidemiol 1993;137:559-68.
3. Taylor LM, Porter JM. Natural history of lower extremity ischaemia. Semin Vasc Surg 1991;4:182-7.
4. Dormandy J, Mahir M, Ascady G, et al. Fate of the patient with chronic limb ischaemia: a review article. J Cardiovasc Surg Torino 1989;30:50-7.
5. Vogt MT, Wolfson SK, Kuller LH. Lower extremity arterial disease and the ageing process: a review. J Clin Epidemiol 1992;45:529-42.
6. Arfvidsson B, Karlsson J, Dahllof AG, Lundholm K, Sullivan M. The impact of intermittent claudication on quality of life evaluated by the sickness impact profile technique. Eur J Clin Invest 1993;23:741-5.
7. Pell JP. Impact of intermittent claudication on quality of life: the Scottish Vascular Audit Group. Eur J Vasc Endovasc Surg 1995;9:469-72.
8. Khaira HS, Hanger R, Shearman CP. Quality of life in patients with intermittent claudication. Eur J Vasc Endovasc Surg 1996;11:65-9.
9. Projections of the population of the United States by age, sex and race: 1983-2080. Current Population Reports, Population Estimates and Projections, US Dept of Commerce, 1984 (Bureau of the Census; Series P-25, No. 952).
10. Cronenwett JL, Warner KG, Zelenock GB, et al. Intermittent claudication: current results of non-operative management. Arch Surg 1984;119:430-6.
11. Rosenbloom MS, Flanigan DP, Schuler JJ, et al. Risk factors affecting the natural history of intermittent claudication. Arch Surg 1988;123:867-70.
12. Jonason T, Ringqvist I. Diabetes mellitus and intermittent claudication: relation between peripheral vascular complications and location of the occlusive atherosclerosis in the legs. Acta Med Scand 1985;218:217-21.
13. Walsh DB, Gilbertson JJ, Zwolak RM, et al. The natural history of superficial femoral artery stenoses. J Vasc Surg 1991;14:299-304.
14. Porter JM, Cutler BS, Lee BY, et al. Pentoxifylline efficacy in the treatment of intermittent claudication: a multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J 1982;104:66-72.
15. Cameron HA, Waller PC, Ramsay LE. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985. Br J Clin Pharmacol 1988;26:569-76.
16. Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: meta-analysis of randomised controlled trials. Can Med Assoc J 1996;155:1053-9.
17. Ernst E, Fialka V. A review of the clinical effectiveness of exercise therapy for intermittent claudication. Arch Intern Med 1993;153:2357-60.
18. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 1995;274:975-80.
19. Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg 1996;23:104-15.
20. Prendiville EJ, Yeager A, O'Donnell TF, et al. Long-term results with the above-knee popliteal expanded PTFE graft. J Vasc Surg 1990;11:517-24.
21. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD. Experience with in situ saphenous vein bypasses during 1981 to 1989: determinant factors of long term patency. J Vasc Surg 1991;13:137-47.
22. Donaldson MC, Mannick JA, Whittemore AD. Femoral-distal bypass with in situ greater saphenous vein: long term results using the Mills valvulotome. Ann Surg 1991;213:457-64.
23. Aalders GJ, van Vroonhoven TJ. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six year results of a randomised clinical trial. J Vasc Surg 1992;16:816-23.
24. Pentecost MJ, Criqui MH, Dorros G, et al. Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremities. Circulation 1994;89:511-31.
25. Gallino A, Mahler F, Probst P, Nachbur B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a five year follow up. Circulation 1984;70:619-23.
26. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty: factors influencing long-term success. Circulation 1991;83:170-80.
27. Rudofsky G, van Laak HH. Treatment costs of peripheral arterial occlusive disease in Germany: a comparison of costs and efficacy. J Cardovasc Pharmacol 1994;23(suppl):S22-5.
28. Van Bemmelen P, Mattos M, Faught WE. Augmentation of blood flow in limbs with occlusive arterial disease by intermittent calf compression. J Vasc Surg 1994;19:1052-58.
29. Morgan RH, Psaila JV, Gardner AMN, Fox RH, Woodcock JP. Arterial flow enhancement by impulse compression. Vasc Surg 1991;25:8-15.
30. Delis K, Labropoulos N, Nicolaides AN, Stansby G, Lumley J. The acute effects of intermittent pneumatic foot vs calf vs simultaneous foot and calf compression on popliteal artery haemodynamics: a comparative study [abstract]. Inter Angiology 1996;2 Suppl 1:6.
31. Delis K, Labropoulos N, Nicolaides AN, et al. Arterial calf inflow augmentation in PVD using intermittent pneumatic compression: effects on popliteal artery haemodynamics [abstract] . Br J Surg 1997;84 Suppl 2:159.
32. Banga JD, Idzerda HHD, Schurman JG, Eikelboom BC. Intermittent pneumatic compression therapy in patients with leg ischaemia [abstract]. Inter Angiology 1995;14 Suppl 1:202.
33. Gaskell P, Parrott JCV. The effect of a mechanical venous pump on the circulation of the feet in the presence of arterial obstruction. Journal of Surgery, Gynaecology and Obstetrics 1978;16:538-92.
34. Porter JM, Moneta GL. International Consensus Committee on Chronic Venous Disease: reporting standards in venous disease: an update. J Vasc Surg 1995;21:635-45.
35. Yao JST. Non-invasive studies of peripheral vascular disease. In: Veith FJ, Hobson R, Williams R, editors. Vascular surgery. New York: McGraw Hill; 1994. p. 90-7.
36. Yao JST. Pressure measurements in the extremity. In: Bernstein EF, editor. Vascular diagnosis. St Louis: Mosby; 1993. p. 169-75.
37. Gardner AMN, Fox RH. Peripheral venous physiology. In: Gardner AMN, Fox RH, editors. The return of blood to the heart. London: John Libbey; 1993. p. 61-88.
38. Fordyce MJF, Ling RM. A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg 1992;74-B(1):45-9.
39. Wilson NV, Das SK, Kakkar VV, et al. Thrombo-embolic prophylaxis in total knee replacement: evaluation of the A-V impulse system. J Bone Joint Surg Br 1992;74:50-2.
40. Bradley JG, Krugener GH, Jager HJ. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty. J Arthroplasty 1993;8:57-61.
41. Santori FS, Vitullo A, Stopponi M, Santori N, Ghera S. Prophylaxis against deep-vein thrombosis in total hip replacement: comparison of heparin and foot impulse pump. J Bone Joint Surg Br 1994;76:579-83.
42. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on prostacyclin production by cultured human endothelial cells. Science 1985;227:1477-9.
43. Yin and yang in vasomotor control [editorial]. Lancet 1988;2:19-20.
44. Endothelins [editorial]. Lancet 1991;337:79-80.
45. Ranjan V, Xiao Z, Diammond SL. Constitutive NOS expression in cultured endothelial cells is elevated by fluid shear stress. Am J Physiol 1995;269:H550-5.
46. Henriksen O. Orthostatic changes of blood flow in subcutaneous tissue in patients with arterial insufficiency of the legs. Scand J Clin Lab Invest 1974;34:103-9.
47. Henriksen O. Local nervous mechanism in regulation of blood flow in human subcutaneous tissue. Acta Physiol Scand 1976;97:385-91.
48. Michel CC. Microcirculation in the limbs in venous hypertension. Medicographia 1989;11:40-2.
49. Rutherford RB, Baker D, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischaemia: revised version. J Vasc Surg 1997;26:517-38.
50. Lewis T. The adjustment of the blood flow to the affected limb in arteriovenous fistula. Clin Sci 1940;4:277-83.
51. Holman E. Problems in the dynamics of blood flow: conditions controlling collateral circulation in the presence of an arteriovenous fistula, following the ligation of the artery. Surgery 1949;26:889-94.
52. Edwards EA, Cohen NR, Marshall MK. Effect of exercise on peripheral pulses. N Engl J Med 1959;260:738-41.
53. John HT, Warren R. The stimulus to collateral circulation. Surgery 1961;49:14-25.
54. Delis K, Azizi ZA, Nicolaides AN, et al. Determining the optimum intermittent pneumatic compression (IPLC) stimulus for lower limb venous emptying using direct pressure measurements [abstract]. Br J Surg 1996;83 Suppl 2:148.
55. Currie IC, Wilson YG, Baird RN, Lamont PM. Treatment of intermittent claudication: the impact on quality of life. Eur J Vase Endovasc Surg 1995;10:356-61.
56. Larsen OA, Lassen NA. Effect of daily muscular exercise in patients with intermittent claudication. Lancet 1966;19:1093-5.
57. Holm J, Dahllof AG, Bjorntorp P, Schersten T. Enzyme studies in muscles of patients with intermittent claudication: effect of training. Scand J Clin Lab Inv 1973;31(suppl):201-5.
58. Strano A, Davi G, Avellone G, Novo S, Pinto A. Doubleblind, crossover study of the clinical efficacy and the hemorheological effects of pentoxifylline in patients with occlusive arterial disease of the lower limbs. Angiology 1984;35:459-66.
59. Mehlsen J, Himmelstrup H, Himmelstrup B, et al. Beneficial effects of intermittent suction and pressure treatment in intermittent claudication. Angiology 1993;44:16-20.
60. Taylor LM Jr, Porter JM. Natural history and non-operative treatment of chronic lower extremity ischaemia. In: Rutherford RB, editor. Vascular surgery. Philadelphia: Saunders; 1995. p. 751-66.
61. de-la-Haye R, Diehm C, Blume J, et al. An epidemiologic study of the value and limits of physical therapy/exercise therapy in Fontaine stage II arterial occlusive disease. Vasa 1992;38(suppl):1-40.
62. Tisi PV, Shearman CP. The evidence for exercise-induced inflammation in intermittent claudication: Should we encourage patients to stop walking? Eur J Vasc Endovasc Surg 1998;15:7-17.
63. Hickman P, Harrison DK, Hill A, et al. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol 1994;36:565-70.
64. Crinnion JN, Homer-Vanniasinkam S, Parkin SM, Gough MJ. The role of neutrophil-endothelial adhesion in skeletal muscle reperfusion injury. Br J Surg 1996;83:251-4.
65. De Weese JA, Leather R, Porter J. Practical guidelines: lower extremity revascularisation. J Vasc Surg 1993;18:280-94.